Lakefront Biotherapeutics NV (LKFT)
NASDAQ: LKFT · Real-Time Price · USD
28.80
+0.53 (1.87%)
At close: Aug 21, 2026, 4:00 PM EDT
28.78
-0.02 (-0.07%)
After-hours: Aug 21, 2026, 7:30 PM EDT

LKFT Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
596.64320.8874.08211.7-217.99-103.23
Depreciation & Amortization
3.3436.8138.3343.6465.5716.24
Other Amortization
3.793.795.92--5.07
Loss (Gain) From Sale of Assets
-1.06-1.06-52.48-1.09-0.02-
Asset Writedown & Restructuring Costs
243.39243.391.24--13.33
Loss (Gain) From Sale of Investments
-66.6350.74-49.98-22.3-6.934.8
Stock-Based Compensation
18.122417.6936.6388.5170.73
Provision & Write-off of Bad Debts
-9.64-9.649.64---
Other Operating Activities
-98.86-2.5-46.12-2.2-50.2-58.18
Change in Accounts Receivable
86.5986.59-31.06-39.1168.9879.86
Change in Inventory
28.8528.8523.04-24.08-34.59-21.17
Change in Unearned Revenue
-954.03-1,071-255.51-661.06-383.62-453.72
Change in Other Net Operating Assets
-77.3932.02-57.0331.82-30.25-35.35
Operating Cash Flow
-226.91-257.46-320.03-405.97-500.54-503.83
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-4.61-13.7-16.72-18.71-27.39-54.21
Sale of Property, Plant & Equipment
2.860.4602.430.74-
Cash Acquisitions
-733.52---7-115.27-
Divestitures
13.8119.43-8.95--28.7
Sale (Purchase) of Intangibles
--0.16-65.39-0.57-9.56-3.67
Investment in Securities
943.13219.59282.1680.27-1,087570.41
Other Investing Activities
70.6783.1929.514.77-70.01
Investing Cash Flow
292.28288.81220.671.19-1,246541.24

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--3.27-4.92-6.77-8.18-7.19
Net Debt Issued (Repaid)
-3.24-3.27-4.92-6.77-8.18-7.19
Issuance of Common Stock
---1.776.73.31
Financing Cash Flow
-6.11-3.27-4.92-5-1.49-3.88

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
5.03-4.461.78-1.5222.2956.76
Miscellaneous Cash Flow Adjustments
----0-0
Net Cash Flow
64.2823.63-102.57-341.31-1,72590.3

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-231.52-271.16-336.75-424.68-527.93-558.03
Free Cash Flow Growth
------
Free Cash Flow Margin
-23.37%-24.38%-122.16%-177.15%-218.83%-238.09%
Free Cash Flow Per Share
-3.51-4.12-5.11-6.44-8.04-8.52
Levered Free Cash Flow
138.21344.64-274.43-119.36-23.64-119.32
Unlevered Free Cash Flow
138.74345.29-273.86-118.26-19.34-112.07

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.290.460.693.8112.4612.54
Cash Income Tax Paid
0.960.37-0.418.174.430.68
Change in Working Capital
-915.98-923.86-320.55-692.44-379.47-430.38
SEC Filings: 10-K · 10-Q